NCRI Press Release, 9 November 2016
Marker for aggressive prostate cancer doubles-up as a drug target
Download the attachmentRecent Tweets
-
Attending #NCRI2018? @breastcancernow are challenging you to describe your research project in a simplified and und… https://t.co/FWJg3Vq6Ai
21 hours ago -
Final call for registrations! Secure your place at #NCRI2018 before midnight: https://t.co/BXFCISwGHF
2 days ago -
Have you registered for #NCRI2018 yet? Standard registration closes tomorrow so this is the last chance to pre-regi… https://t.co/4salHmRNeH
3 days ago
What's Happening
- 9 Oct 2018NCRI’s Chairs’ Forum round-up: latest on our work to accelerate cancer research
- 13 Aug 2018Register now for the 5th Annual Children's Cancer & Leukaemia Trials Meeting: 26 November 2018
- 25 Jul 2018Redesigning clinical research to improve outcomes for older people
- 18 May 2018NCRI Consumer Membership Applications to the CSGs - Closing Soon!
- 3 May 2018Dr Iain Frame appointed NCRI CEO
RSS Feed